Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Noubar Afeyan

Stanley Lapidus

Anthony P. Shuber

Exact Sciences Corporation

AgelessRx provides anti-aging treatments supported by longevity science. The organization offers various therapies to assist individuals in managing health concerns related to aging.

Metric
Company Name	Exact Sciences Corporation	AgelessRx
Symbol	EXAS
MSH ID	COM:EXACTSCIENCES	COM:AGELESSRX
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Diagnostics & Research	Medical Services
Country	US	US
Stage
Employee Count	6.50K
Website	exactsciences.com	agelessrx.com
LinkedIn
Founders

Metric
Market Cap	8.36B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	2.50B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.85B
EBITDA	-13.13M
Operating Income	-215.01M
Net Income	-204.15M
EPS	-1.13
Diluted EPS	-1.13
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.74
Operating Profit Margin	-0.06
EBITDA Margin	-0.01
Net Profit Margin	-0.07
Return on Equity	-0.06
Return on Assets	-0.03
Return on Capital Employed	-0.03

COM:EXACTSCIENCES

Exact Sciences Corp

Last Close

53.07

22/11 21:00

Market Cap

8.36B

Beta: -

Volume Today

2.00M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-39.93
P/B Ratio	3.61
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.09
EV Multiple	-62.44

Metric
Days Sales Outstanding	30.25
Days Payables Outstanding	42.65
Days Inventory Outstanding	71.12
Operating Cycle	104.93
Cash Conversion Cycle	75.65
Asset Turnover	0.40

Metric
Operating Cash Flow	156.12M
Free Cash Flow	31.93M
Cash Flow to Debt	0.06
Operating Cash Flow/Sales	0.06
Free Cash Flow Yield	-0.00

Metric
Cash & Equivalents	605.38M
Accounts Receivable	-43.42M
Inventory	127.47M
Goodwill	2.37B
Debt to Capitalization	0.46
Debt to Assets	0.75
Current Ratio	2.41
Quick Ratio	1.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04
R&D to Revenue	0.17
SG&A to Revenue	0.36